{
    "root": "36941d95-638d-4a3c-8888-209eea0e0722",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "MEKTOVI",
    "value": "20250320",
    "ingredients": [
        {
            "name": "BINIMETINIB",
            "code": "181R97MR71",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_145371"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        }
    ],
    "indications": {
        "text": "mektovi kinase inhibitor indicated : \u2022 combination encorafenib , treatment patients unresectable metastatic melanoma braf v600e v600k mutation , detected fda-approved test . ( 1.1 , 2.1 ) \u2022 combination encorafenib , treatment adult patients metastatic non-small cell lung cancer ( nsclc ) braf v600e mutation , detected fda-approved test . ( 1.2 , 2.1 )",
        "doid_entities": [
            {
                "text": "melanoma (DOID:1909)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1909"
            },
            {
                "text": "non-small cell lung cancer (DOID:3908)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3908"
            },
            {
                "text": "lung cancer (DOID:1324)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1324"
            },
            {
                "text": "cancer (DOID:162)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_162"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "melanoma \u2022 confirm presence braf v600e v600k mutation tumor specimens prior initiation mektovi . ( 2.1 ) \u2022 recommended dose 45 mg orally twice daily combination encorafenib . take mektovi without food . ( 2.2 ) \u2022 patients moderate severe hepatic impairment recommended dose 30 mg orally twice daily . ( 2.4 , 8.6 ) nsclc \u2022 confirm presence braf v600e mutation tumor plasma specimens prior initiating mektovi . ( 2.1 ) \u2022 recommended dose 45 mg orally twice daily combination encorafenib . take mektovi without food . ( 2.2 )",
        "doid_entities": [
            {
                "text": "melanoma (DOID:1909)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1909"
            },
            {
                "text": "nsclc (DOID:3908)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3908"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "severe hepatic impairment",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_447788"
            }
        ]
    },
    "warningsAndPrecautions": "mektovi ( binimetinib ) supplied 15 mg yellow/dark yellow , unscored biconvex oval film-coated tablets debossed stylized `` `` one side `` 15 `` side , available bottles 180 tablets ( ndc 70255-010-02 ) .",
    "adverseReactions": "none .",
    "indications_original": "MEKTOVI is a kinase inhibitor indicated: \u2022 in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test. ( 1.1 , 2.1 ) \u2022 in combination with encorafenib, for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation, as detected by an FDA-approved test. ( 1.2 , 2.1 )",
    "contraindications_original": "Melanoma \u2022 Confirm the presence of BRAF V600E or V600K mutation in tumor specimens prior to the initiation of MEKTOVI. ( 2.1 ) \u2022 The recommended dose is 45 mg orally twice daily in combination with encorafenib. Take MEKTOVI with or without food. ( 2.2 ) \u2022 For patients with moderate or severe hepatic impairment the recommended dose is 30 mg orally twice daily. ( 2.4 , 8.6 ) NSCLC \u2022 Confirm the presence of BRAF V600E mutation in tumor or plasma specimens prior to initiating MEKTOVI. ( 2.1 ) \u2022 The recommended dose is 45 mg orally twice daily in combination with encorafenib. Take MEKTOVI with or without food. ( 2.2 )",
    "warningsAndPrecautions_original": "MEKTOVI (binimetinib) is supplied as 15 mg yellow/dark yellow, unscored biconvex oval film-coated tablets debossed with a stylized \"A\" on one side and \"15\" on the other side, available in bottles of 180 tablets (NDC 70255-010-02).",
    "adverseReactions_original": "None.",
    "drug": [
        {
            "name": "MEKTOVI",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_145371"
        }
    ]
}